Stacie L. Daugherty, MD, MSPH

Medical Director of Clinical Trials | Senior Clinician Investigator

Stacie L. Daugherty, MD, MSPH, is the Medical Director of Clinical Trials and a Senior Clinician Investigator at the Institute for Health Research. Her research focuses on finding ways to deliver equitable, high quality cardiovascular care to all people.

Dr. Daugherty received her medical training at the University of Minnesota Medical School, in Minneapolis, Minnesota and completed an internship, residency, and Cardiology Fellowship at the University of Colorado School of Medicine. She also received a Master of Science in Public Health from the University of Colorado Health Sciences Center. Her research teams are working to bridge the fields of social psychology and health services research to execute unique approaches to studying and addressing health disparities. Dr. Daugherty also serves as the medical director for the clinical trials program at Kaiser Permanente Colorado.

Dr. Daugherty is a practicing clinical physician in Cardiology with the Colorado Permanente Medical Group at Kaiser Permanente Colorado. She is also a Professor of Medicine at the University of Colorado School of Medicine in the Division of Cardiology.

Selected Research:

  • Structural Conditions and Health After Release from Prison: The SCHARP study
  • The goal of the SCHARP study is to learn about structural conditions, such as policies, practices, and attitudes that affect the health of people who have been released from prison. We will measure organizational structural conditions in diverse healthcare systems, link exposure to structural conditions to care access and health outcomes among a cohort of people released from prison. We will examine outcomes according to baseline cardiovascular risk and disseminate recommended organizational practices for improving access and outcomes.

    • Funder: National Heart, Lung, and Blood Institute, NIH
    • Award End Date: 06/30/2027

  • Using AI text messaging technology to improve AHA's LE8 Health Behaviors: Chat 4 Heart Health
  • The goal of the Chat 4 Heart Health Study is to improve control of cardiovascular risk factors by engaging patients from federally qualified health centers who have elevated cardiovascular risk with a technology-based self-management intervention focusing on control of the American Heart Association’s Life’s Essential 8 (LE8) lifestyle factors. We will conduct a pragmatic, patient-level randomized intervention across three health systems which include FQHCs.

    • Funder: National Heart, Lung, and Blood Institute, NIH
    • Award End Date: 05/31/2028

  • Cardiology Teleconsult Pilot Study
  • The study aims to evaluate the value of a Cardiology Teleconsultation model from the perspective of KP members, physicians referring to cardiology, cardiologists, and KPCO operational leaders. The assessment will inform the decision to disseminate the cardiology teleconsultation model to all cardiology clinics and other consultative services in the health system.  

    • Funder: IMPROVE – Innovative Methods to Promote Regional Operational Value and Efficiency, Kaiser Permanente Colorado
    • Award End Date: 12/2023

  • Improving Communication and Healthcare Outcomes for Patients with Communication Disabilities: the INTERACT Trial
  • The study aims to address patients’ communication challenges (barriers) in the primary care setting (use of services) by comparing two interventions for increasing providers’ use of communication strategies (mediators: providers’ communication skills) among patients with communications disorders.  

    • Funder: Patient-Centered Outcomes Research Institute
    • Award End Date: 06/30/2023

  • Disparities in Patient-Centered Communication Experienced by Patients with Communication Disorders
  • The overall purpose of this research is to compare medical students’ communication behaviors with patients with communication disorders (CD) and to evaluate medical students’ implicit and explicit biases towards people with CD.

    • Funder: National Institute on Deafness and Other Communication Disorders
    • Award End Date: 08/31/2021

  • Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities
  • The objective of the Hypertension and Values (HYVALUE) multicenter trial was to use an intervention targeting stereotype threat, values affirmation, to reduce racial disparities in hypertension.

    • Funder: National Heart, Lung, and Blood Institute, NIH
    • Award End Date: 05/31/2021

  • Discrimination and Allostatic Load among American Indians
  • The overall goal of this project is to better understand the effects of discrimination on CVD risk, via allostatic load, in American Indians/ Alaska Natives (AI/AN). The three specific aims were to assess AI/AN individuals’ exposure to discrimination and examine associations with (1) an established panel of biomarkers of allostatic load, (2) physiological reactivity and recovery in a laboratory discrimination-challenge task, and (3) ambulatory BP during 24 hours of real-life experience sampling.

    • Funder: American Heart Association, Strategically Focused Research Network on Cardiovascular Disparities
    • Award End Date: 06/30/2019

  • An Intervention to Increase Engagement with Hypertension Care for American Indian Patients
  • This study conducted a randomized controlled trial testing values affirmation on improving adherence to medication in American Indian and White patients with hypertension.

    • Funder: American Heart Association, Strategically Focused Research Network on Cardiovascular Disparities
    • Award End Date: 06/30/2019